Efficacy and Safety of Alirocumab and Evolocumab as Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors in Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis
Article in Current Medicinal Chemistry (January 2024)
The most recent citing publications are shown below. View all 31 publications that cite this research output on Dimensions.
Article in Current Medicinal Chemistry (January 2024)
Article in Chinese Pediatric Emergency Medicine (October 2023)
Article in Molecular Biology Reports (September 2023)